glp-1 drugs and anxiety medications used to treat diabetes obesity may also help alleviate symptoms of and depression The risk of depression, anxiety,
Description
In any other case, the risk of bias was deemed as being of some concern
Participants were patients with class II or III obesity treated with either MBS or GLP-1 RAs who were enrolled in Highmark insurance for at least 6 months prior to index treatment and had follow-up data available for at least 12 months
PMID 41500720
That is a mindset shift that needs to happen
The result is high quality health care that is accessible, comprehensive, and, most of all, personalized
